Work

Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase Inhibitors

Year: 2024

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.10.022

Authors: Florence K. Keane, Beow Y. Yeap, Melin J. Khandekar, Jessica J. Lin, Ibiayi Dagogo-Jack, Lecia V. Sequist, Zofia Piotrowska, Henning Willers

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: PROTON THERAPY RESEARCH AND TREATMENT CENTER, Dana Farber/Harvard Cancer Center SPORE in Lung Cancer

OpenAlex ID: W4404548967

FWCI: 2.039

Cites: 15

Cited by: 8

Related to: 10